Schedule 13G ownership disclosure
Rhythm Pharmaceuticals Inc
Security class unavailable · CUSIP: 76243J105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,201,260
- Percent of class
- 9.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000769993-23-000106
- Form type
- SC 13G
- Filer
- GOLDMAN SACHS GROUP INC
- CIK
- CIK 886982
- Filed
- Feb 08, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership